ArticleKidney medicine2022

Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies.

Joel Topf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.